ConductScience.org, home

Paper368262

The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.

Dinarello CA and 3 others. J Infect Dis, 1978. Cited by 114 papers, by iCite.

Cite this record

ConductScience Library. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. Papers, record 368262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/368262

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
PubMed
Journal
J Infect Dis
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
114
iCite
Relative citation ratio, by iCite
3.32
iCite
Revised in PubMed
2019-05-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dinarello CAC A
2Elin RJR J
3Chedid LL
4Wolff SMS M

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acetylmuramyl-Alanyl-IsoglutamineMajor topic
Adjuvants, ImmunologicMajor topic
GlycopeptidesMajor topic
PyrogensMajor topic
Animals
Endotoxins
Escherichia coli
Humans
In Vitro Techniques
Limulus Test
Neutrophils
Phagocytes
Rabbits
Staphylococcus
Stimulation, Chemical

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.

PMIDTitleJournalYearIn PapersSource
42347646Chimeric Pathogen-Associated Molecular Patterns (PAMPs) as Vaccine Adjuvants.Vaccines (Basel)2026https://conductscience.org/library/papers/42347646PubMed
41528771Identification and Evaluation of Benzimidazole- Agonists of Innate Immune Receptor NOD2.ACS Infect Dis2026https://conductscience.org/library/papers/41528771PubMed
39344184Distinctive Immune Signatures Driven by Structural Alterations in Desmuramylpeptide NOD2 Agonists.J Med Chem2024https://conductscience.org/library/papers/39344184PubMed
38393912Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors.J Alzheimers Dis2024https://conductscience.org/library/papers/38393912PubMed
36237313Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency.Front Oncol2022https://conductscience.org/library/papers/36237313PubMed
34043358Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity.J Med Chem2021https://conductscience.org/library/papers/34043358PubMed
33585281Activity of Tracheal Cytotoxin of Bordetella pertussis in a Human Tracheobronchial 3D Tissue Model.Front Cell Infect Microbiol2020https://conductscience.org/library/papers/33585281PubMed
31798878Translation of peptidoglycan metabolites into immunotherapeutics.Clin Transl Immunology2019https://conductscience.org/library/papers/31798878PubMed
16148175Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative and gram-positive infections in leukopenic rats.Clin Diagn Lab Immunol2005https://conductscience.org/library/papers/16148175PubMed
8751911Tolerance to appetite suppression induced by peptidoglycan.Infect Immun1996https://conductscience.org/library/papers/8751911PubMed
8335342Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis.Infect Immun1993https://conductscience.org/library/papers/8335342PubMed
8039898Peptidoglycan fragments decrease food intake and body weight gain in rats.Infect Immun1994https://conductscience.org/library/papers/8039898PubMed
7506415Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/7506415PubMed
7500012Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses.J Exp Med1995https://conductscience.org/library/papers/7500012PubMed
7420023Central pyrogenic activity of muramyl dipeptide.J Exp Med1980https://conductscience.org/library/papers/7420023PubMed
7216446Endogenous pyrogen production by human blood monocytes stimulated by staphylococcal cell wall components.Infect Immun1981https://conductscience.org/library/papers/7216446PubMed
7035868Muramyl peptides. Chemical structure, biological activity and mechanism of action.Mol Cell Biochem1981https://conductscience.org/library/papers/7035868PubMed
7035362Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.Infect Immun1982https://conductscience.org/library/papers/7035362PubMed
7019079Stimulation of nonspecific resistance to infection induced by 6-O-acyl muramyl dipeptide analogs in mice.Infect Immun1981https://conductscience.org/library/papers/7019079PubMed
6835353Immunostimulation with muramyl dipeptide and its desmethyl analogue: Studies of non-specific resistance to pulmonary blastomycosis in inbred mouse strains.Mycopathologia1983https://conductscience.org/library/papers/6835353PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/368262

GET https://conductscience.org/api/papers/v1/368262/cited_by?page=2